WO1992019234A3 - Methode de traitement/prevention de l'usage de drogue - Google Patents
Methode de traitement/prevention de l'usage de drogue Download PDFInfo
- Publication number
- WO1992019234A3 WO1992019234A3 PCT/US1992/002808 US9202808W WO9219234A3 WO 1992019234 A3 WO1992019234 A3 WO 1992019234A3 US 9202808 W US9202808 W US 9202808W WO 9219234 A3 WO9219234 A3 WO 9219234A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dependent
- substance
- individual
- treating
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Méthode destinée à soigner l'être humain qui est ou était dépendant d'une drogue. Elle consiste à administrer à l'individu une quantité effective d'une aminotétraline de la formule (I). Soigner, c'est 1) traiter un individu qui est dépendant (soit physiquement, soit psychologiquement) d'une drogue; 2) empêcher un individu qui prend une drogue pour se distraire, mais n'en est pas dépendant, de devenir dépendant de la même drogue ou d'autres drogues; 3) empêcher un individu qui était par le passé, mais ne l'est plus, dépendant d'une drogue, de le redevenir; 4) prévenir la dépendance de la drogue d'individus qui n'ont jamais consommé de la drogue, mais dont les modes de vie et activités laissent croire aux médecins qu'ils risquent de prendre une drogue à des fins de distraction et/ou de devenir dépendants de différentes drogues.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4511382A JPH06506951A (ja) | 1991-04-26 | 1992-04-13 | 物質乱用の治療／予防方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69323891A | 1991-04-26 | 1991-04-26 | |
| US693,238 | 1991-04-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1992019234A2 WO1992019234A2 (fr) | 1992-11-12 |
| WO1992019234A3 true WO1992019234A3 (fr) | 1993-01-07 |
Family
ID=24783880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1992/002808 WO1992019234A2 (fr) | 1991-04-26 | 1992-04-13 | Methode de traitement/prevention de l'usage de drogue |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0581865A1 (fr) |
| JP (1) | JPH06506951A (fr) |
| AU (1) | AU1915192A (fr) |
| CA (1) | CA2106197A1 (fr) |
| WO (1) | WO1992019234A2 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2527328A1 (fr) | 2008-04-01 | 2012-11-28 | Abbott GmbH & Co. KG | Tétrahydroisoquinoléines, compositions pharmaceutiques les contenant et leur utilisation en thérapie |
| AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
| US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| JP2014521682A (ja) | 2011-08-05 | 2014-08-28 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | アミノクロマン、アミノチオクロマンおよびアミノ−１，２，３，４−テトラヒドロキノリン誘導体、これらを含有する医薬組成物、ならびに治療におけるこれらの使用 |
| WO2013072520A1 (fr) | 2011-11-18 | 2013-05-23 | AbbVie Deutschland GmbH & Co. KG | Dérivés aminobenzocycloheptène, aminotétraline, aminoindane et phénalkylamine n-substitués, composition pharmaceutiques les contenant, et leur application thérapeutique |
| US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| CA2924689A1 (fr) | 2013-10-17 | 2015-04-23 | AbbVie Deutschland GmbH & Co. KG | Derives d'aminochromane, d'aminothiochromane et d'amino-1,2,3,4-tetrahydroquinoleine, compositions pharmaceutiques contenant ceux-ci et leur utilisation therapeutique |
| CA2924699A1 (fr) | 2013-10-17 | 2015-04-23 | AbbVie Deutschland GmbH & Co. KG | Derives d'aminotetraline et d'aminoindane, compositions pharmaceutiques les contenant et leur utilisation en therapie |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0064964A1 (fr) * | 1981-05-08 | 1982-11-17 | Astra Läkemedel Aktiebolag | 1-Alcoyl-2-aminotétralines thérapeutiquement utiles |
| US4800204A (en) * | 1987-05-07 | 1989-01-24 | Mueller Peter S | Method of controlling tobacco use |
| US4935429A (en) * | 1985-10-25 | 1990-06-19 | Dackis Charles A | Method of treating psychostimulant addiction |
| US4994486A (en) * | 1989-05-31 | 1991-02-19 | Abbott Laboratories | Dopaminergic compounds |
-
1992
- 1992-04-13 AU AU19151/92A patent/AU1915192A/en not_active Abandoned
- 1992-04-13 EP EP92911383A patent/EP0581865A1/fr not_active Withdrawn
- 1992-04-13 JP JP4511382A patent/JPH06506951A/ja active Pending
- 1992-04-13 WO PCT/US1992/002808 patent/WO1992019234A2/fr not_active Application Discontinuation
- 1992-04-13 CA CA002106197A patent/CA2106197A1/fr not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0064964A1 (fr) * | 1981-05-08 | 1982-11-17 | Astra Läkemedel Aktiebolag | 1-Alcoyl-2-aminotétralines thérapeutiquement utiles |
| US4935429A (en) * | 1985-10-25 | 1990-06-19 | Dackis Charles A | Method of treating psychostimulant addiction |
| US4800204A (en) * | 1987-05-07 | 1989-01-24 | Mueller Peter S | Method of controlling tobacco use |
| US4994486A (en) * | 1989-05-31 | 1991-02-19 | Abbott Laboratories | Dopaminergic compounds |
Non-Patent Citations (5)
| Title |
|---|
| Alcohol, vol. 7, no. 3, May/June 1990, Pergamon Press plc, (US), G.F. KOOB et al.: "Pharmacology of drug self-administration", pages 193-197, see page 195 * |
| European Journal of Pharmacology, vol. 182, no. 2, 3 July 1990, Elsevier Science Publishers B.V. (Biomedical Division), M.F. PIERCEY et al.: "Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232", pages 219-226, see whole document * |
| J. Med. Chem., vol. 25, no. 3, 1982, American Chemical Society, D.S. FRIES et al.: "Aminotetralins as narcotic antagonists. 2. Synthesis and opiate-related activity of 1-phenyl-3-aminotetralins", pages 216-220, see whole document * |
| Journal of Neural Transmission, vol. 65, no. 1, 1986, Springer-Verlag, K. SVENSSON et al.: "(+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors", pages 1-27, see whole document * |
| Psychopharmacology, vol. 107, no. 1, May 1992, Springer-Verlag, (Berlin, DE), P.M. CALLAHAN et al.: "Effects of the putative dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 on the discriminative stimulus properties of cocaine", pages 73-77, see whole document * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2106197A1 (fr) | 1992-10-27 |
| EP0581865A1 (fr) | 1994-02-09 |
| AU1915192A (en) | 1992-12-21 |
| JPH06506951A (ja) | 1994-08-04 |
| WO1992019234A2 (fr) | 1992-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1992019234A3 (fr) | Methode de traitement/prevention de l'usage de drogue | |
| CA2231803A1 (fr) | Extrait lipidique possedant une activite anti-inflammatoire | |
| GB9519661D0 (en) | Fatty acid treatment | |
| AU674894C (en) | Treatment of conditions and disease | |
| AU8138687A (en) | Agents for combating pests and plant treatment agents | |
| CA2164866A1 (fr) | Traitement de troubles et de maladies neuromusculaires a l'aide de differents serotypes de botulinum | |
| OA09736A (en) | "Human interleukin-3 and muteins thereof". | |
| OA09194A (en) | "Insecticidal treatment and compositions therefor". | |
| FR2600900B1 (fr) | Dispositif de protection et/ou de maintien d'une partie d'un corps humain ou animal, notamment les jambes d'un joueur de football, et procede de realisation d'un tel dispositif | |
| IT1222395B (it) | Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare | |
| AU639097B2 (en) | Medicament for treating hyperlipidaemia and/or atherosclerosis | |
| Kemp | Model-based monitoring of human sleep stages | |
| EP0328924A3 (fr) | Composés de thiénotriazolodiazépine et ses applications pharmaceutiques | |
| AU3861989A (en) | Method for the treatment and the diagnosis of coronary heart disease | |
| EP0744176A3 (fr) | Médicaments pour inhiber les pertes osseuses | |
| AU1926188A (en) | N-benzoyl-n'-2,5-dihalo-4-perfluoroalkoxyphenylureas, their preparation and use in the control of pests | |
| EP0207505A3 (fr) | Utilisation d'un prényl cétone dans la préparation d'un médicament contre la gastrite | |
| ZA924128B (en) | New combination preparations for treatment of Parkinson's disease. | |
| EP0666745A4 (fr) | Procedes de diagnostic et de traitement de la maladie de parkinson. | |
| AU6678194A (en) | Agents for the prevention and treatment of huntington's disease and other neurological disorders | |
| EP0286802A3 (fr) | Emploi de l'ofloxacine pour le traitement ou la prophylaxie topique des troubles péridontiques | |
| AU3881889A (en) | Human interferon-gamma, process to prepare said human interferon-gamma, and its use | |
| EP0343832A3 (fr) | Composés de 5H-pyrazolo(4,3-a)quinolizin-5-one aux activités thérapeutiques | |
| AU1162788A (en) | Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases | |
| Ceriani et al. | Creamatocrit and pH measurements of human milk. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MG MN MW NO PL RO RU SD US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MG MN MW NO PL RO RU SD US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 1992911383 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2106197 Country of ref document: CA |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1992911383 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 1992911383 Country of ref document: EP |